How can healthcare providers support adherence to INH therapy?

Supporting adherence to isoniazid (INH) therapy is critical for the effective management of tuberculosis (TB), and education coupled with regular follow-ups plays a vital role in ensuring patients stick to their treatment regimens. Educating patients about the importance of completing their therapy, the potential side effects of the medication, and the consequences of non-adherence helps them understand why consistent medication intake is necessary for their health. Moreover, regular follow-ups allow healthcare providers to monitor the patient's progress, address any concerns or side effects, and reinforce the importance of following the treatment plan. This ongoing support fosters a trusting relationship between the provider and the patient, which can enhance adherence and ultimately improve health outcomes.

Other options may not effectively encourage adherence. Simply prescribing more medications could overwhelm patients or contribute to confusion about their treatment plan. Offering free treatment is beneficial in reducing financial barriers, but without proper education and follow-up, patients may still struggle with adherence. Limiting patient visits is counterproductive, as frequent contact with healthcare providers can help patients stay motivated and engaged in their treatment. Therefore, the most effective approach to support adherence is through continuous education and consistent follow-up engagements.